Major pharmaceutical companies, including Eli Lilly, AstraZeneca, and Boehringer Ingelheim, are adjusting investments and operations in Europe.

The entities involved

• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
• AstraZeneca →

  British-Swedish pharmaceutical company

  • AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
  • Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52
• Boehringer Ingelheim →

  German pharmaceutical company

  • Sheila Denton was appointed as General Counsel & Corporate Secretary at Boehringer Ingelheim.Mon 15:03
  • Boehringer Ingelheim and Palatin Technologies reported $13.2 million in revenue from their Fiscal 2026 collaboration.Mon 13:31

Related events

• Several healthcare ETFs hold major pharmaceutical companies like Eli Lilly, J&J, and Novo Nordisk as top 3 positions, leading to competition for investor capital.Jun 19